Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
10.1093/annonc/mdq784
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117118 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-117118 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1171182023-10-29T23:18:30Z Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies Yong, W.P. Goh, B.C. Soo, R.A. Toh, H.C. Ethirajulu, K. Wood, J. Novotny-Diermayr, V. Lee, S.C. Yeo, W.L. Chan, D. Lim, D. Seah, E. Lim, R. Zhu, J. CANCER SCIENCE INSTITUTE OF SINGAPORE Histone deacetylase Pharmacodynamics Pharmacokinetics 10.1093/annonc/mdq784 Annals of Oncology 22 11 2516-2522 ANONE 2014-12-12T08:01:45Z 2014-12-12T08:01:45Z 2011-11 Article Yong, W.P., Goh, B.C., Soo, R.A., Toh, H.C., Ethirajulu, K., Wood, J., Novotny-Diermayr, V., Lee, S.C., Yeo, W.L., Chan, D., Lim, D., Seah, E., Lim, R., Zhu, J. (2011-11). Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies. Annals of Oncology 22 (11) : 2516-2522. ScholarBank@NUS Repository. https://doi.org/10.1093/annonc/mdq784 09237534 http://scholarbank.nus.edu.sg/handle/10635/117118 000296292700025 Scopus |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
Histone deacetylase Pharmacodynamics Pharmacokinetics |
| spellingShingle |
Histone deacetylase Pharmacodynamics Pharmacokinetics Yong, W.P. Goh, B.C. Soo, R.A. Toh, H.C. Ethirajulu, K. Wood, J. Novotny-Diermayr, V. Lee, S.C. Yeo, W.L. Chan, D. Lim, D. Seah, E. Lim, R. Zhu, J. Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies |
| description |
10.1093/annonc/mdq784 |
| author2 |
CANCER SCIENCE INSTITUTE OF SINGAPORE |
| author_facet |
CANCER SCIENCE INSTITUTE OF SINGAPORE Yong, W.P. Goh, B.C. Soo, R.A. Toh, H.C. Ethirajulu, K. Wood, J. Novotny-Diermayr, V. Lee, S.C. Yeo, W.L. Chan, D. Lim, D. Seah, E. Lim, R. Zhu, J. |
| format |
Article |
| author |
Yong, W.P. Goh, B.C. Soo, R.A. Toh, H.C. Ethirajulu, K. Wood, J. Novotny-Diermayr, V. Lee, S.C. Yeo, W.L. Chan, D. Lim, D. Seah, E. Lim, R. Zhu, J. |
| author_sort |
Yong, W.P. |
| title |
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies |
| title_short |
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies |
| title_full |
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies |
| title_fullStr |
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies |
| title_full_unstemmed |
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies |
| title_sort |
phase i and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, sb939, in patients with refractory solid malignancies |
| publishDate |
2014 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/117118 |
| _version_ |
1781789597961814016 |